Skip to main content

Dermatology Expert Insights

First Report Managed Care
By Peter Sonnenreich, Bassem Wolley, Katherine Moody, and Linda Geisler Alice B. Gottlieb, MD, PhD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York. This scientific presentation was given by Alice B. Gottlieb, MD, PhD, at a dinner program titled “HANDS…
First Report Managed Care
By Julie Gould Jean Liew, MD, senior fellow in the Division of Rheumatology at the University of Washington, discusses the health care burden patients with both cardiovascular disease and psoriatic arthritis experience and explains why the development of more guidelines in the future can help…
First Report Managed Care
This article originally appeared in the April issue of The Dermatologist.  By Melissa Weiss, Associate Editor Within the last decade, advances in the understanding of psoriasis and new therapeutic options have transformed the treatment landscape for this chronic disease. Discovery of the…
First Report Managed Care
Recent advances in the ability to treat moderate-to-severe atopic dermatitis with targeted therapies have changed the game for these patients. However, cost considerations could significantly impact budgets as these new agents come to the market. Understanding the Burden Chronic, lifelong atopic…
First Report Managed Care
Improvements in psoriasis therapies over the past decade have changed the way this disease is treated and managed, including increased use of biologic therapies, which are protein-based drugs made from living cells. Biologic agents have altered the treatment landscape in the management of moderate-…
Back to Top